Skip to content

LONA LONA Change in Lease Liabilities

Change in Lease Liabilities at other companies

Arvinas logo
ArvinasARVN
-$400K+20.0%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
-$313K-1.3%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
-$386K-18.8%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$549K-221%
Immunome logo
ImmunomeIMNM
-$161K-160%

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+223%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's change in lease liabilities?
LONA (LONA) reported change in lease liabilities of -$112K in Q1 2026.
How has LONA's change in lease liabilities changed year-over-year?
LONA's change in lease liabilities decreased by 12.0% year-over-year, from -$100K to -$112K.
What is the long-term trend for LONA's change in lease liabilities?
Over 2 years (2023 to 2025), LONA's change in lease liabilities has grown at a 12.7% compound annual growth rate (CAGR), from -$326K to -$414K.
What does change in lease liabilities mean?
Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.